Drug index search
| Drug Name | Synonyms | Target | Datasets | Drug Id |
|---|---|---|---|---|
| Sunitinib | Sutent, Sunitinib Malate, SU-11248 | PDGFR, KIT, VEGFR, FLT3, RET, CSF1R | GDSC1 | 5 |
| PHA-665752 | PHA665752, PHA 665752 | MET | GDSC1 | 6 |
| Cyclopamine | SMO | GDSC1 | 17 | |
| AZ628 | AZ-628, AZ 628 | BRAF | GDSC1 | 29 |
| Imatinib | Gleevec, STI-571 | ABL, KIT, PDGFR | GDSC1 | 34 |
| NVP-TAE684 | NVP-TAE 684, TAE684, TAE-684 | ALK | GDSC1 | 35 |
| Saracatinib | AZD0530, AZD-0530, AZ-10353926 | ABL, SRC | GDSC1 | 38 |
| S-Trityl-L-cysteine | NSC 83265, Tritylcysteine | KIF11 | GDSC1 | 41 |
| Z-LLNle-CHO | Z-L-Norleucine-CHO, Gamma-Secretase Inhibitor 1 | gamma-secretase | GDSC1 | 45 |
| GNF-2 | KIN001-013 | BCR-ABL | GDSC1 | 52 |
| CGP-60474 | KIN001-019, CGP60474, CGP 60474 | CDK1,CDK2,CDK5,CDK7,CDK9, PKC | GDSC1 | 53 |
| CGP-082996 | CINK4, KIN001-021 | CDK4 | GDSC1 | 54 |
| A-770041 | KIN001-111 | LCK, FYN | GDSC1 | 55 |
| WH-4-023 | KIN001-112 | SRC, LCK | GDSC1 | 56 |
| WZ-1-84 | KIN001-123 | BMX | GDSC1 | 59 |
| BMS-509744 | KIN001-127, ITK inhibitor | ITK | GDSC1 | 63 |
| CMK | KIN001-128 | RSK2 | GDSC1 | 64 |
| Pyrimethamine | Daraprim, Chloridine | Dihydrofolate reductase (DHFR) | GDSC1 | 71 |
| JW-7-52-1 | 0 | MTOR | GDSC1 | 83 |
| A-443654 | KIN001-139 | AKT1, AKT2, AKT3 | GDSC1 | 86 |
| GW843682X | GW843682X (AN-13) | PLK1 | GDSC1 | 87 |
| Parthenolide | HDAC1 | GDSC1 | 89 | |
| GSK319347A | KIN001-135, IKK-3 inhibitor | IKK | GDSC1 | 91 |
| TGX221 | TGX-221, Tgx 221 | PI3Kbeta | GDSC1 | 94 |
| XMD8-85 | ERK5-IN-1 | ERK5, BET | GDSC1 | 106 |
| Seliciclib | Roscovitine, CYC-202, AL-39256 | CDK2, CDK7, CDK9 | GDSC1 | 110 |
| Salubrinal | EIF-2alpha Inhibitor | EIF2A | GDSC1 | 111 |
| Doxorubicin | Anthracycline | GDSC1 | 1386 | |
| Etoposide | Etopophos, Vepesid, Eposin, VP-16 | TOP2 | GDSC1 | 134 |
| Mitomycin-C | Mytozytrex, NSC-26980, MMC, Mitosol, Mitozytrex | DNA crosslinker | GDSC1 | 136 |
| NSC-87877 | NSC 87877 | SHP-1 (PTPN6), SHP-2 (PTPN11) | GDSC1 | 147 |
| QS11 | 944328-88-5 | ARFGAP1 | GDSC1 | 151 |
| CP466722 | CP-466722, CP 466722, 1080622-86-1 | ATM | GDSC1 | 152 |
| Midostaurin | PKC412, benzoylstaurosporine, CGP-41251 | PKC, PPK, FLT1, c-FGR, others | GDSC1 | 153 |
| Ponatinib | AP24534, AP-24534, KIN001-192, Iclusig | ABL, PDGFRA, VEGFR2, FGFR1, SRC, TIE2, FLT3 | GDSC1 | 155 |
| JNK-9L | BAZ2A, BAZ2B | GDSC1 | 1205 | |
| PF-562271 | PF-00562271 | FAK, FAK2 | GDSC1 | 158 |
| HG6-64-1 | KIN001-206 | BRAF | GDSC1 | 159 |
| JQ12 | HDAC1, HDAC2 | GDSC1 | 164 | |
| DMOG | Dimethyloxalylglcine | HIF-PH | GDSC1 | 165 |
| FTI-277 | Farnesyl-transferase (FNTA) | GDSC1 | 166 | |
| OSU-03012 | AR-12, OSU 03012, OSU03012, PDK1 inhibitor AR-12 | PDK1 (PDPK1) | GDSC1 | 167 |
| Shikonin | Anchusin | not defined | GDSC1 | 170 |
| AKT inhibitor VIII | Akti-1/2, KIN001-102 | AKT1, AKT2, AKT3 | GDSC1 | 228 |
| Embelin | Emberine, Embelic acid | XIAP | GDSC1 | 172 |
| FH535 | PPARgamma, PPARdelta | GDSC1 | 173 | |
| PAC-1 | GTPL5238 | Procaspase-3, Procaspase-7 | GDSC1 | 175 |
| IPA-3 | IPA 3 | PAK1 | GDSC1 | 176 |
| GSK650394 | GSK-650394, GSK 650394 | SGK2, SGK3 | GDSC1 | 177 |
| BAY-61-3606 | Syk Inhibitor, BAY-613606 | SYK | GDSC1 | 178 |
| Thapsigargin | Octanoic acid | SERCA | GDSC1 | 180 |
| Bexarotene | LG-100069, Targretin, Targret, Targrexin, Targretyn, Bexarotenum | Retinioic X receptor (RXR) agonist | GDSC1 | 186 |
| LFM-A13 | DDE-28 | BTK | GDSC1 | 192 |
| GW-2580 | GX2580, CFMS receptor tyrosine kinase inhibitor | CSF1R | GDSC1 | 193 |
| Phenformin | DBI | Biguanide agent | GDSC1 | 196 |
| Bryostatin 1 | Bryostatin | PKC | GDSC1 | 197 |
| Pazopanib | Votrient | CSF1R, KIT, PDGFRA, PDGFRB | GDSC1 | 199 |
| Dacinostat | NVP-LAQ824, LAQ824 | HDAC1 | GDSC1 | 200 |
| Epothilone B | Patupilone, EpoB, EPO906, GNF-PF-193 | Microtubule stabiliser | GDSC1 | 201 |
| Tipifarnib | Zarnestra | Farnesyl-transferase (FNTA) | GDSC1 | 204 |
| AS601245 | JNK1, JNK2, JNK2 | GDSC1 | 207 | |
| Ispinesib Mesylate | SB-715992 | KSP | GDSC1 | 208 |
| TL-2-105 | not defined | GDSC1 | 211 | |
| AT-7519 | AT7519 | CDK1, CDK2, CDK4, CDK6, CDK9 | GDSC1 | 219 |
| TAK-715 | KIN001-201, TAK 715 | p38alpha, p38beta | GDSC1 | 221 |
| BX-912 | PDK1 (PDPK1) | GDSC1 | 222 | |
| ZSTK474 | KIN001-167, ZSTK-474, ZSTK 474 | PI3K (class 1) | GDSC1 | 223 |
| AS605240 | KIN001-173, AS-605240 | PI3Kgamma | GDSC1 | 224 |
| Genentech Cpd 10 | AURKA, AURKB | GDSC1 | 225 | |
| GSK1070916 | GSK-1070916 | AURKA, AURKC | GDSC1 | 226 |
| Enzastaurin | LY317615 | PKCB | GDSC1 | 229 |
| GSK429286A | ROCK1, ROCK2 | GDSC1 | 230 | |
| FMK | KIN001-242 | RSK | GDSC1 | 231 |
| QL-XII-47 | IRAK1 | GDSC1 | 1155 | |
| IC-87114 | PI3Kdelta | GDSC1 | 236 | |
| Idelalisib | CAL-101, Zydelig | PI3Kdelta | GDSC1 | 238 |
| Cabozantinib | BMS-907351, XL-184, Cometriq | VEGFR, MET, RET, KIT, FLT1, FLT3, FLT4, TIE2,AXL | GDSC1 | 249 |
| WZ3105 | SRC, ROCK2, NTRK2, FLT3, IRAK1, others | GDSC1 | 252 | |
| XMD14-99 | ALK, CDK7, LTK, others | GDSC1 | 253 | |
| Quizartinib | AC220, AC 220, AC-220, Asp-2689 | FLT3 | GDSC1 | 254 |
| CP724714 | CP-724714 | ERBB2 | GDSC1 | 255 |
| JW-7-24-1 | LCK | GDSC1 | 256 | |
| NPK76-II-72-1 | PLK3 | GDSC1 | 257 | |
| STF-62247 | STF62247 | Autophagy inducer | GDSC1 | 258 |
| NG-25 | TAK1 | GDSC1 | 1167 | |
| TL-1-85 | TAK1, MAP4K2 | GDSC1 | 261 | |
| FR-180204 | FR 180204, FR180204, ERK Inhibitor II | ERK1, ERK2 | GDSC1 | 263 |
| ACY-1215 | HDAC6 | GDSC1 | 264 | |
| Tubastatin A | HDAC1, HDAC6, HDAC8 | GDSC1 | 265 | |
| Zibotentan | ZD4054, ZD-4054 | Endothelin-1 receptor (EDNRA) | GDSC1 | 266 |
| NSC-207895 | XI-006, NSC207895 | MDM4 | GDSC1 | 269 |
| VNLG/124 | HDAC inhibitor XV | HDAC,RAR | GDSC1 | 271 |
| AR-42 | HDAC-42, AR 42, AR42 | HDAC1 | GDSC1 | 272 |
| CUDC-101 | CUDC 101 | HDAC1-10, EGFR, ERBB2 | GDSC1 | 273 |
| Belinostat | PXD101, PXD-101 | HDAC1 | GDSC1 | 274 |
| CAY10603 | HDAC1, HDAC6 | GDSC1 | 276 | |
| Linifanib | ABT-869, ABT 869 | VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT | GDSC1 | 277 |
| BIX02189 | BIX 02189 | MEK5, ERK5 | GDSC1 | 279 |
| Alectinib | CH5424802, CH 542802, Alecensa | ALK | GDSC1 | 281 |
| Pelitinib | EKB-569, EKB 569 | EGFR | GDSC1 | 282 |
| Omipalisib | GSK2126458, GSK-2126458, EX-8678, GSK458 | PI3K (class 1), MTORC1, MTORC2 | GDSC1 | 283 |
| JNJ38877605 | MET | GDSC1 | 284 | |
| SU11274 | MET | GDSC1 | 285 | |
| KIN001-236 | HDAC6, HDAC10 | GDSC1 | 286 | |
| KIN001-244 | PDK1 inhibitor 7 | PDK1 | GDSC1 | 287 |
| WHI-P97 | AC1L1GQE, KIN001-055 | JAK3 | GDSC1 | 288 |
| KIN001-042 | GSK3B | GDSC1 | 289 | |
| KIN001-260 | Bayer IKKb inhibitor, ACHP | CDC7 | GDSC1 | 290 |
| KIN001-266 | CDC7 | GDSC1 | 291 | |
| Masitinib | AB1010, Masivet | KIT, PDGFRA, PDGFRB | GDSC1 | 292 |
| Amuvatinib | MP470, MP 470, MP-470 | KIT, PDGFRA, FLT3 | GDSC1 | 293 |
| MPS-1-IN-1 | MPS1 | GDSC1 | 294 | |
| NVP-BHG712 | BHG712 | EPHB4, RAF, SRC, ABL | GDSC1 | 295 |
| OSI-930 | OSI 930 OSI930 | KIT, VEGFR2 | GDSC1 | 298 |
| CX-5461 | CX5461, CX 5461 | RNA Polymerase 1 | GDSC1 | 300 |
| PHA-793887 | PHA793887, PHA 793887 | CDK2, CDK7, CDK5 | GDSC1 | 301 |
| PI-103 | PI-103, PI103, PI 103 | PI3Kalpha, DAPK3, CLK4, PIM3, HIPK2 | GDSC1 | 302 |
| PIK-93 | PIK 93, PIK93 | PK3CG | GDSC1 | 303 |
| SB52334 | SB-52334, SB 52334 | ALK5 | GDSC1 | 304 |
| TPCA-1 | IKK2 | GDSC1 | 305 | |
| Fedratinib | TG101348, TG-101348, SAR302503, SAR-302503 | JAK2 | GDSC1 | 306 |
| Y-39983 | ROCK | GDSC1 | 309 | |
| YM201636 | YM-201636, YM 201636 | PIKFYVE | GDSC1 | 310 |
| Tivozanib | AV-951, AV 951, KRN-951, KIL8951, ASP-4130 | VEGFR1, VEGFR2, VEGFR3, PDGFR, KIT | GDSC1 | 312 |
| WYE-125132 | mTOR | GDSC1 | 317 | |
| GSK690693 | GSK 690693, GSK-690693 | AKT1, AKT2, AKT3 | GDSC1 | 326 |
| SNX-2112 | SNX 2112 | HSP90 | GDSC1 | 328 |
| QL-XI-92 | DDR1 | GDSC1 | 329 | |
| XMD13-2 | MRCKB | GDSC1 | 330 | |
| QL-X-138 | BTK | GDSC1 | 331 | |
| XMD15-27 | CAMK2 | GDSC1 | 332 | |
| T0901317 | TO-901317, TO901317 | LXR, FXR | GDSC1 | 333 |
| Selisistat | EX-527, EX 527 | SIRT1 | GDSC1 | 341 |
| Tenovin-6 | SIRT | GDSC1 | 342 | |
| THZ-2-49 | CDK9 | GDSC1 | 344 | |
| KIN001-270 | CDK9 inhibitor, CDK9-IN-1 | CDK9 | GDSC1 | 345 |
| THZ-2-102-1 | CDK7 | GDSC1 | 346 | |
| AT7867 | AKT | GDSC1 | 356 | |
| CI-1033 | EGFR, ERBB2, ERBB4 | GDSC1 | 362 | |
| PF-00299804 | EGFR, ERBB2, ERBB4 | GDSC1 | 363 | |
| TWS119 | GSK3 | GDSC1 | 366 | |
| Torin 2 | mTOR | GDSC1 | 371 | |
| Pilaralisib | XL-147 | PI3K | GDSC1 | 372 |
| GSK1059615 | PI3K | GDSC1 | 374 | |
| Voxtalisib | XL-765, SAR245409 | PI3K (class 1), DNAPK, MTOR | GDSC1 | 375 |
| Brivanib | BMS-540215 | VEGFR, PDGFR | GDSC1 | 376 |
| BIBF-1120 | VEGFR, PDGFR, FGFR | GDSC1 | 380 | |
| AST-1306 | EGFR, ERBB4 | GDSC1 | 381 | |
| Apitolisib | GDC0980 | mTOR, PI3K | GDSC1 | 382 |
| LIMK1 inhibitor BMS4 | LIMK1 | GDSC1 | 406 | |
| kb NB 142-70 | PKD | GDSC1 | 407 | |
| Sphingosine Kinase 1 Inhibitor II | PF-543 | Sphingosine Kinase | GDSC1 | 408 |
| eEF2K Inhibitor | A-484954 | eEF2K | GDSC1 | 409 |
| MetAP2 Inhibitor | A832234 | MetAP2 | GDSC1 | 410 |
| Venotoclax | ABT-199, Veneclexta, GDC-0199 | BCL-2 selective | GDSC1 | 412 |
| CPI-613 | Metabo, Mitochondria | GDSC1 | 415 | |
| CAY10566 | Stearoyl-CoA desaturase | GDSC1 | 416 | |
| Ara-G | 9-??-D-Arabinofuranosyl guanine | Anti-metabolite | GDSC1 | 427 |
| Pemetrexed | TYMS | GDSC1 | 428 | |
| Flavopiridol | CDK | GDSC1 | 432 | |
| C-75 | FAS | GDSC1 | 435 | |
| CAP-232 | TT-232, TLN-232 | Glycolysis | GDSC1 | 436 |
| Trichostatin A | HDAC | GDSC1 | 437 | |
| Panobinostat | Farydak, LBH589 | HDAC | GDSC1 | 438 |
| IMD-0354 | IKKb | GDSC1 | 442 | |
| ETP-45835 | MNK1, MNK2 | GDSC1 | 447 | |
| CD532 | AURKA | GDSC1 | 449 | |
| NSC319726 | P53 Mut specific | GDSC1 | 461 | |
| ARRY-520 | KIF11 | GDSC1 | 474 | |
| A-83-01 | TGFB | GDSC1 | 477 | |
| LDN-193189 | BMP | GDSC1 | 478 | |
| FTY-720 | Fingolimod hydrochloride; Gilenya; TDI-132; Imusera; Gilenia | S1P | GDSC1 | 546 |
| BAM7 | Bax activator | GDSC1 | 552 | |
| Kobe2602 | RAS effector | GDSC1 | 563 | |
| RU-SKI 43 | Shh | GDSC1 | 576 | |
| AICA Ribonucleotide | AICAR, N1-(b-D-Ribofuranosyl)-5-aminoimidazole-4-carboxamide | AMPK agonist | GDSC1 | 1001 |
| CI-1040 | CI 1040, PD-18435, PD-184352, 212631-79-3 | MEK1, MEK2 | GDSC1 | 1015 |
| VX-702 | VX702, VX 702 | p38 | GDSC1 | 1028 |
| CRT0105950 | JNK1, JNK2, JNK3 | GDSC1 | 1070 | |
| CRT0105446 | mTOR, LCK | GDSC1 | 1071 | |
| Cetuximab | Erbitux, IMC-C225, C225, IMC-225, L01XC06 | EGFR | GDSC1 | 1114 |
| FS106 | CHEK1 | GDSC1 | 1128 | |
| Capivasertib | AZ5363 | AKT | GDSC1 | 1136 |
| HG-5-113-01 | AURKA | GDSC1 | 1142 | |
| HG-5-88-01 | TAK1, M4K2 | GDSC1 | 1143 | |
| THZ-1-87 | BTK, BMX | GDSC1 | 1145 | |
| XMD11-50 | LRRK2, ERK5 | GDSC1 | 1157 | |
| XMD11-85h | LRRK2, ERK5 | GDSC1 | 1158 | |
| ZG-10 | JNK1 | GDSC1 | 1161 | |
| XMD8-92 | XMD 8-92 | ERK5 | GDSC1 | 1164 |
| THZ-2-98-01 | IRAK1 | GDSC1 | 1165 | |
| QL-VIII-58 | MTOR, ATR | GDSC1 | 1166 | |
| CRT0160829 | CDC7 | GDSC1 | 1183 | |
| AZ20 | ATR | GDSC1 | 1184 | |
| KU-60019 | ATM | GDSC1 | 1185 | |
| FS112 | KS6B1 (p70S6K) | GDSC1 | 1186 | |
| CCT245232 | HSF1 | GDSC1 | 1187 | |
| CCT245467 | HSF1 | GDSC1 | 1188 | |
| FY026 | [(para-cymene)osmium(N,N-dimethylphenlyazopyridine)(iodide)]hexafluorophophate | GDSC1 | 1195 | |
| FY069 | [(biphenyl)osmium(5-fluoro-phenlyazopyridine)(iodide)]hexafluorophophate | GDSC1 | 1196 | |
| ZL049 | [(diphenyltetramethylcyclopentadienyl)iridium(III)(2-phenylpyridine)(chloride)] | GDSC1 | 1197 | |
| FY012 | GDSC1 | 1198 | ||
| torin2 | MTOR, ATM, ATR, DNAPK | GDSC1 | 1202 | |
| QL-XII-61 | BMX, BTK | GDSC1 | 1203 | |
| HG-6-71-01 | DDR1, DDR2, SRC | GDSC1 | 1204 | |
| I-BET-151 | GSK12100151A | BRD2, BRD3, BRD4 | GDSC1 | 1232 |
| (5Z)-7-Oxozeaenol | 5Z-7-Oxozeaenol, LL-Z1640-2 | TAK1 | GDSC1 | 1242 |
| N22899-6-C1 | Peptidyl arginine deaminase (PAD) | GDSC1 | 1251 | |
| N23918-95-7 | JMJ histone demethylase | GDSC1 | 1252 | |
| N24798-49-A1 | JMJ histone demethylase | GDSC1 | 1253 | |
| GSK-J4 | KDM6B | GDSC1 | 1254 | |
| rTRAIL | TRAIL receptor agonist | GDSC1 | 1261 | |
| UNC1215 | UNC-1215 | L3MBTL3 | GDSC1 | 1262 |
| UNC0642 | G9A, GLP | GDSC1 | 1263 | |
| ICL1100013 | N-myristoyltransferase 1/2 | GDSC1 | 1266 | |
| 965-D2 | MKNK1, MKNK2, PIM1, PIM3 | GDSC1 | 1359 | |
| 993-D2 | MKNK1, MKNK2 | GDSC1 | 1360 | |
| BAY ACCi | ACACA | GDSC1 | 1362 | |
| BAY AKT1 | AKT1, AKT2, AKT3 | GDSC1 | 1363 | |
| BAY-HDAC11_1 | HDAC11 | GDSC1 | 1364 | |
| BAY-HDAC11_2 | HDAC11 | GDSC1 | 1365 | |
| BAY-HDAC11_4 | HDAC11 | GDSC1 | 1367 | |
| BAY-MPS1 | MPS1 | GDSC1 | 1368 | |
| BAY-MPS-combo-1 (paclitaxel 5 uM) | TTK and microtubules | GDSC1 | 1369 | |
| BAY-MPS-combo 2 (paclitaxel 1 uM) | TTK and microtubules | GDSC1 | 1370 | |
| ZL109 | DNA damage | GDSC1 | 1379 | |
| AZD3514 | SN1019841295 | AR | GDSC1 | 1382 |
| Bleomycin (10 uM) | dsDNA break induction | GDSC1 | 1392 | |
| AZD6094 | SN1042487586 | MET | GDSC1 | 1403 |
| Dyrk1b_0191 | SN1008982787 | DYRK1B | GDSC1 | 1407 |
| AZD4877 | SN1055467765 | EG5 | GDSC1 | 1409 |
| EphB4_9721 | SN1076287848 | EPHB4 | GDSC1 | 1413 |
| AZD8931 | SN0216062465 | EGFR, ERBB2, ERBB3 | GDSC1 | 1416 |
| FEN1_3940 | SN1106019609 | FEN1 | GDSC1 | 1419 |
| FGFR_0939 | SN1043317881 | FGFR4 | GDSC1 | 1421 |
| FGFR_3831 | SN1037992934 | FGFR1, FGFR2, FGFR3, FGFR4 | GDSC1 | 1422 |
| BPTES | SN1041594574 | GLS | GDSC1 | 1425 |
| AZD7969 | SN1098976045 | GSK3B | GDSC1 | 1426 |
| IAP_7638 | SN1043547481 | IAP | GDSC1 | 1429 |
| IGFR_3801 | SN1056768819 | IGFR1 | GDSC1 | 1430 |
| AZD1480 | SN1044232195 | JAK1, JAK2 | GDSC1 | 1432 |
| JAK1_3715 | SN1042605297 | JAK1 | GDSC1 | 1433 |
| JAK3_7406 | SN1014281280 | JAK3 | GDSC1 | 1434 |
| MCT1_6447 | SN0177231247 | MCT1 | GDSC1 | 1436 |
| MCT4_1422 | SN1043999849 | MCT4 | GDSC1 | 1437 |
| AZD8835 | SN1040214596 | PI3Kalpha, PI3Kdelta | GDSC1 | 1445 |
| PI3Ka_4409 | SN1037097676 | PI3Kalpha, PI3Kdelta | GDSC1 | 1446 |
| PLK_6522 | SN1077317349 | PLK1, PLK2, PLK3 | GDSC1 | 1451 |
| RAF_9304 | SN1034259943 | ARAF, BRAF, CRAF | GDSC1 | 1453 |
| PARP_9495 | SN1024601395 | PARP1, PARP2, PARP7 | GDSC1 | 1458 |
| PARP_0108 | SN1044053371 | PARP1, PARP2, PARP6 | GDSC1 | 1459 |
| PARP_9482 | SN1031920820 | PARP1, PARP2, PARP5a | GDSC1 | 1460 |
| TANK_1366 | SN1032446568 | Tankyrase 1/2 (PARP5a, PARP5b) | GDSC1 | 1461 |
| TTK_3146 | SN1080714093 | TTK | GDSC1 | 1464 |
| PFI-3 | BDF00016096 | PB1, SMARCA4, SMARCA2 | GDSC1 | 1530 |
| I-CBP112 | EP300, CBP | GDSC1 | 1531 | |
| Camptothecin | Camptothecine, (+)-Camptothecin | TOP1 | GDSC2 | 1003 |
| Vinblastine | Velban | Microtubule destabiliser | GDSC2 | 1004 |
| Cisplatin | cis-Diammineplatinum(II) dichloride, Platinol, CIS-DDP | DNA crosslinker | GDSC2 | 1005 |
| Cytarabine | Ara-Cytidine, Arabinosyl Cytosine, U-19920 | Antimetabolite | GDSC2 | 1006 |
| Docetaxel | RP-56976, Taxotere | Microtubule stabiliser | GDSC2 | 1819 |
| Methotrexate | Abitrexate, Amethopterin, Rheumatrex, Trexall, Folex | Antimetabolite | GDSC2 | 1008 |
| Tretinoin | ATRA, Vesanoid, Renova, Atralin, Tretin-X, Avita | Retinoic acid | GDSC2 | 1009 |
| Gefitinib | ZD-1839, Iressa | EGFR | GDSC2 | 1010 |
| Navitoclax | ABT-263, ABT263, ABT 263 | BCL2, BCL-XL, BCL-W | GDSC2 | 1011 |
| Vorinostat | Zolinza, SAHA, suberanilohydroxamic acid, suberoylanilide hydroxamic acid, MK-0683 | HDAC inhibitor Class I, IIa, IIb, IV | GDSC2 | 1012 |
| Nilotinib | Tasigna, AMN 107 | ABL | GDSC2 | 1013 |
| Refametinib | RDEA119, BAY-86-9766, BAY 869766 | MEK1, MEK2 | GDSC2 | 1014 |
| Temsirolimus | CCI-779, Torisel | MTOR | GDSC2 | 1016 |
| Olaparib | AZD2281, KU0059436, Lynparza | PARP1, PARP2 | GDSC2 | 1017 |
| Veliparib | ABT-888, ABT888, ABT 888 | PARP1, PARP2 | GDSC2 | 1018 |
| Bosutinib | SKI-606, Bosulif | SRC, ABL, TEC | GDSC2 | 1019 |
| Lenalidomide | CDC-501, CC-5013, Revlimid | CRBN | GDSC2 | 1020 |
| Axitinib | AG-13736, Inlyta | PDGFR, KIT, VEGFR | GDSC2 | 1021 |
| AZD7762 | AZD-7762, AZD 7762 | CHEK1, CHEK2 | GDSC2 | 1022 |
| GW441756 | GW 441756 | NTRK1 | GDSC2 | 1023 |
| Lestaurtinib | CEP-701, SP-924, SPM-924, A-154475, KT-555 | FLT3, JAK2, NTRK1, NTRK2, NTRK3 | GDSC2 | 1024 |
| SB216763 | SB-216763, SB 216763 | GSK3A, GSK3B | GDSC2 | 1025 |
| Tanespimycin | 17-AAG, BMS-722782 | HSP90 | GDSC2 | 1026 |
| Motesanib | AMG-706, AMG 706, AMG706 | VEGFR, RET, KIT, PDGFR | GDSC2 | 1029 |
| KU-55933 | KU55933 | ATM | GDSC2 | 1030 |
| Elesclomol | STA-4783 | HSP90 | GDSC2 | 1031 |
| Afatinib | BIBW2992, Tovok, Gilotrif | EGFR, ERBB2 | GDSC2 | 1032 |
| Vismodegib | GDC0449, Erivedge | SMO | GDSC2 | 1033 |
| Staurosporine | Broad spectrum kinase inhibitor | GDSC2 | 1034 | |
| PLX-4720 | PLX4720, PLX 4720 | BRAF | GDSC2 | 1036 |
| BX795 | BX-795 | TBK1, PDK1 (PDPK1), IKK, AURKB, AURKC | GDSC2 | 1037 |
| NU7441 | KU-57788, NU-7432, NU-7741 | DNAPK | GDSC2 | 1038 |
| SL0101 | SL-0101, SL 0101-1 | RSK, AURKB, PIM1, PIM3 | GDSC2 | 1039 |
| Doramapimod | BIRB-796, BIRB 796 | p38, JNK2 | GDSC2 | 1042 |
| JNK Inhibitor VIII | JNK | GDSC2 | 1043 | |
| Wee1 Inhibitor | 681640, Wee1 Inhibitor | WEE1, CHEK1 | GDSC2 | 1046 |
| Nutlin-3a (-) | MDM2 | GDSC2 | 1047 | |
| Mirin | MRE11 | GDSC2 | 1048 | |
| PD173074 | PD-173074, PD 173074 | FGFR1, FGFR2, FGFR3 | GDSC2 | 1049 |
| ZM447439 | ZM-447439, ZM 447439 | AURKA, AURKB | GDSC2 | 1050 |
| Alisertib | MLN8237 | AURKA | GDSC2 | 1051 |
| RO-3306 | CDK1 | GDSC2 | 1052 | |
| MK-2206 | MK 2206, MK2206 | AKT1, AKT2 | GDSC2 | 1053 |
| Palbociclib | PD0332991, PD-0332991, PF-00080665-73 | CDK4, CDK6 | GDSC2 | 1054 |
| Dactolisib | NVP-BEZ235, BEZ235 | PI3K (class 1), MTORC1, MTORC2 | GDSC2 | 1057 |
| Pictilisib | GDC-0941, GDC0941, RG-7621 | PI3K (class 1) | GDSC2 | 1058 |
| AZD8055 | AZD-8055 | MTORC1, MTORC2 | GDSC2 | 1059 |
| PD0325901 | PD-0325901, PD 0325901 | MEK1, MEK2 | GDSC2 | 1060 |
| SB590885 | SB-590885 | BRAF | GDSC2 | 1061 |
| Selumetinib | SN1103949345, AZD1480 | MEK1, MEK2 | GDSC2 | 1736 |
| CCT007093 | PPM1D | GDSC2 | 1067 | |
| Obatoclax Mesylate | GX15-070MS, Obatoclax, GX15-070 | BCL2, BCL-XL, BCL-W, MCL1 | GDSC2 | 1068 |
| EHT-1864 | EHT 1864 | RAC1, RAC2, RAC3 | GDSC2 | 1069 |
| Avagacestat | BMS-708163, BMS 708163 | Amyloid beta20, Amyloid beta40 | GDSC2 | 1072 |
| 5-Fluorouracil | 5-FU | Antimetabolite (DNA & RNA) | GDSC2 | 1073 |
| Dasatinib | BMS-354825-03, BMS-354825, Sprycel | ABL, SRC, Ephrins, PDGFR, KIT | GDSC2 | 1079 |
| Paclitaxel | BMS-181339-01, Taxol, Onxol, Paxene, Praxel, Abraxane | Microtubule stabiliser | GDSC2 | 1080 |
| Crizotinib | Xalkori, PF2341066, PF-2341066, PF 2341066 | MET, ALK, ROS1 | GDSC2 | 1083 |
| Rapamycin | AY-22989, Sirolimus, WY-090217, Torisel, Rapamune | MTORC1 | GDSC2 | 1084 |
| Sorafenib | Nexavar, 284461-73-0, BAY 43-9006 | PDGFR, KIT, VEGFR, RAF | GDSC2 | 1085 |
| BI-2536 | PLK1, PLK2, PLK3 | GDSC2 | 1086 | |
| Irinotecan | Camptosar, (+)-Irinotecan, Irinotecanum, irinotecan hydrochloride | TOP1 | GDSC2 | 1088 |
| Oxaliplatin | DNA alkylating agent | GDSC2 | 1806 | |
| BMS-536924 | BMS 536924 | IGF1R, IR | GDSC2 | 1091 |
| GSK1904529A | GSK-1904529A, GSK 1904529A | IGF1R, IR | GDSC2 | 1093 |
| Tozasertib | MK 0457,MK-0457,MK-045, VX-680 VX 680 VX-68 | AURKA, AURKB, AURKC, others | GDSC2 | 1096 |
| PF-4708671 | PF 4708671, PF4708671 | S6K1 | GDSC2 | 1129 |
| PRIMA-1MET | Prima 1MET, APR-246 | TP53 activation | GDSC2 | 1131 |
| Serdemetan | JNJ-26854165 | MDM2 | GDSC2 | 1133 |
| TW 37 | TW37, TW-37 | BCL2, BCL-XL, MCL1 | GDSC2 | 1149 |
| Erlotinib | Tarceva, RG-1415, CP-358774, OSI-774, Ro-508231, R-1415 | EGFR | GDSC2 | 1168 |
| CCT-018159 | CCT018159, CCT 018159 | HSP90 | GDSC2 | 1170 |
| Rucaparib | PF-01367338, AG-014699, AG-14447, AG-14699 | PARP1, PARP2 | GDSC2 | 1175 |
| Niraparib | MK-4827, MK4827 | PARP1, PARP2 | GDSC2 | 1177 |
| MK-1775 | AZD1775, Adavosertib | WEE1, PLK1 | GDSC2 | 1179 |
| Dinaciclib | SCH727965, SCH 727965, SCH-727-965, MK-7965 | CDK1, CDK2, CDK5, CDK9 | GDSC2 | 1180 |
| Gemcitabine | Gemzar, LY-188011 | Pyrimidine antimetabolite | GDSC2 | 1190 |
| Bortezomib | PS-341, LDP-341, Velcade | Proteasome | GDSC2 | 1191 |
| GSK269962A | GSK 269962A | ROCK1, ROCK2 | GDSC2 | 1192 |
| SB505124 | SB 505124, SB505124 | TGFBR1, ACVR1B, ACVR1C | GDSC2 | 1194 |
| Tamoxifen | Nolvadex, Soltamox, Zynoplex, ICI-46474, Kessar | ESR1 | GDSC2 | 1199 |
| Fulvestrant | ESR | GDSC2 | 1816 | |
| EPZ004777 | EPZ-004777 | DOT1L | GDSC2 | 1237 |
| YK-4-279 | YK 4-279 | RNA helicase A | GDSC2 | 1239 |
| Piperlongumine | Piplartine | Induces reactive oxygen species | GDSC2 | 1243 |
| Daporinad | APO866, FK866, FK866 | NAMPT | GDSC2 | 1248 |
| BMS-345541 | IKK-1, IKK-2 | GDSC2 | 1249 | |
| AZ960 | AZ 960, AZ-960 | JAK2, JAK3 | GDSC2 | 1250 |
| Talazoparib | BMN-673, BMN 973 | PARP1, PARP2 | GDSC2 | 1259 |
| XAV939 | NVP-XAV939, XAV-939, XAV 939 | TNKS1, TNKS2 | GDSC2 | 1268 |
| Trametinib | GSK1120212, Mekinist | MEK1, MEK2 | GDSC2 | 1372 |
| Dabrafenib | GSK2118436, Tafinlar | BRAF | GDSC2 | 1373 |
| Temozolomide | Temodar, Temodal, M-39831, SCH 52365 | DNA alkylating agent | GDSC2 | 1375 |
| Bleomycin (50 uM) | dsDNA break induction | GDSC2 | 1378 | |
| AZD5438 | SN1057898678 | CDK2 | GDSC2 | 1401 |
| IAP_5620 | SN1043546339 | IAP | GDSC2 | 1428 |
| AZD2014 | SN1103949359 | mTORC1, mTORC2 | GDSC2 | 1441 |
| AZD1208 | SN1028350371 | PIM1, PIM2, PIM3 | GDSC2 | 1449 |
| AZD1332 | SN1061387896 | NTRK1, NTRK2, NTRK3 | GDSC2 | 1463 |
| SN-38 | 7-Ethyl-10-Hydroxy-Camptothecin, SN 38 | TOP1 | GDSC2 | 1494 |
| Bicalutamide | ICI-176334, Casodex, Cosudex, ICI 176334 | AR | GDSC2 | 1502 |
| Ruxolitinib | INCB-18424, Ruxolitinib Phosphate, Jakafi | JAK1, JAK2 | GDSC2 | 1507 |
| Linsitinib | OSI-906, ASP-7487 | IGF1R | GDSC2 | 1510 |
| Epirubicin | Ellence, Farmorubicin, IMI-28 | Anthracycline | GDSC2 | 1511 |
| Cyclophosphamide | Cytoxan, Neosar, Cyclophosphamid, Procytox, Cyclophosphane | Alkylating agent | GDSC2 | 1512 |
| Pevonedistat | MLN4924, MLN 4924, MLN-4924 | NAE | GDSC2 | 1529 |
| Sapitinib | AZD8931 | EGFR, ERBB2, ERBB3 | GDSC2 | 1549 |
| Uprosertib | GSK2141795, GSK2141795C, GSK-2141795 | AKT1, AKT2, AKT3 | GDSC2 | 2106 |
| LCL161 | XIAP, IAP1, IAP2 | GDSC2 | 1557 | |
| Lapatinib | Tykerb, Tyverb | EGFR, ERBB2 | GDSC2 | 1558 |
| Luminespib | AUY922, VER-52296,NVP-AUY922, AUY | HSP90 | GDSC2 | 1559 |
| Alpelisib | BYL719, BYL-719, NVP-BYL719 | PI3Kalpha | GDSC2 | 1560 |
| Taselisib | GDC-0032, GDC0032, RG7604 | PI3K (beta sparing) | GDSC2 | 1561 |
| EPZ5676 | EPZ-5676, Pinometostat | DOT1L | GDSC2 | 1563 |
| SCH772984 | CS-1421 | ERK1, ERK2 | GDSC2 | 1564 |
| IWP-2 | Wnt Inhibitor IWP-2 | PORCN | GDSC2 | 1576 |
| Leflunomide | Sulol, SU-101, HWA-486, Arava | Pyrimidine synthesis inhibitor | GDSC2 | 1578 |
| GSK2801 | 1-(7-(2-methylsulfonyl-phenyl)-4-propoxy-1-aza-bicyclo[4.3.0]nona-2,4,6,8-tetraen-9-yl)-ethanone | GDSC2 | 1580 | |
| Bromosporine | ethyl N-[6-(3-methanesulfonamido-4-methylphenyl)-3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-yl]carbamate | CECR2, BRD2, BRD4, BRD9 | GDSC2 | 1581 |
| SGC-CBP30 | 8-(3-chloro-4-methoxy-phenethyl)-4-(3,5-dimethyl-isoxazol-4-yl)-9-(2-(morpholin-4-yl)-propyl)-7,9-diaza-bicyclo[4.3.0]nona-1(6),2,4,7-tetraene | EP300, CBP | GDSC2 | 1582 |
| GSK-LSD1 | N-((1R,2S)-2-phenylcyclopropyl)piperidin-4-amine | KDM1 | GDSC2 | 1583 |
| BDOCA000347a | 4-bromo-N-(6-methoxy-1,3-dimethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)-2-methylbenzenesulfonamide | BRPF1, BRPF2, BRPF3 | GDSC2 | 1584 |
| BDF00022089a | BRPF1, BRPF2, BRPF3 | GDSC2 | 1585 | |
| BDILV000379a | 4-(4-(1-methyl-1H-pyrazol-4-yl)-1-(2-(1-methyl-1H-pyrazol-4-yl)ethyl)-4,5-dihydro-1H-imidazol-5-yl)benzonitrile | BAZ2A, BAZ2B | GDSC2 | 1586 |
| Entinostat | MS-275 | HDAC1, HDAC3 | GDSC2 | 1593 |
| OSI-027 | A-1065-5 | MTORC1, MTORC2 | GDSC2 | 1594 |
| LGK974 | LGK-974 | PORCN | GDSC2 | 1598 |
| VE-822 | VE 822, VE822, Berzosertib | ATR | GDSC2 | 1613 |
| WZ4003 | WZ 4003 | NUAK1, NUAK2 | GDSC2 | 1614 |
| CZC24832 | GTPL6653 | PI3Kgamma | GDSC2 | 1615 |
| AZD5582 | GTPL7710, AOB5560 | XIAP, cIAP | GDSC2 | 1617 |
| GSK2606414 | AK175551 | PERK | GDSC2 | 1618 |
| PFI3 | PFI-3, PFI 3, AOB2221 | Polybromo 1, SMARCA4, SMARCA2 | GDSC2 | 1620 |
| PCI-34051 | AK298746 | HDAC8, HDAC6, HDAC1 | GDSC2 | 1621 |
| Wnt-C59 | AOB3540, AK161197 | PORCN | GDSC2 | 1622 |
| I-BET-762 | GSK525762A | BRD2, BRD3, BRD4 | GDSC2 | 1624 |
| RVX-208 | 1044870-39-4, Apabetalone | BRD4 | GDSC2 | 1625 |
| OTX015 | Birabresib, OTX-015, MK-8628 | BRD2, BRD3, BRD4 | GDSC2 | 1626 |
| GSK343 | EZH2 | GDSC2 | 2037 | |
| ML323 | GTPL7898, AOB2313, | USP1, UAF1 | GDSC2 | 1629 |
| Entospletinib | GS-9973 | SYK | GDSC2 | 1630 |
| PRT062607 | P505-15, PRT-2607, BIIB-057 | SYK | GDSC2 | 1631 |
| Ribociclib | LEE011, NVP-LEE011, LEE011-BBA | CDK4, CDK6 | GDSC2 | 1632 |
| AGI-6780 | AK162157 | IDH2 R140Q mutant | GDSC2 | 1634 |
| Picolinici-acid | Picolinate | Inflammatory related | GDSC2 | 1635 |
| AZD5153 | SN1045566955, AZD5153 | BRD4 | GDSC2 | 1706 |
| CDK9_5576 | SN1047226266, CDK9_5576 | CDK9 | GDSC2 | 1708 |
| CDK9_5038 | SN1047483750, CDK9_5038 | CDK9 | GDSC2 | 1709 |
| Eg5_9814 | SN1047613775, Eg5_9814 | KSP11 | GDSC2 | 1712 |
| ERK_2440 | SN1051032892, ERK_2440 | ERK1,ERK2 | GDSC2 | 1713 |
| ERK_6604 | SN1047587618, ERK_6604 | ERK1,ERK2 | GDSC2 | 1714 |
| IRAK4_4710 | SN1050852374, IRAK4_4710 | IRAK4 | GDSC2 | 1716 |
| JAK1_8709 | SN1049200060, JAK1_8709 | JAK1 | GDSC2 | 1718 |
| AZD5991 | SN1049446612, AZD5991 | MCL1 | GDSC2 | 1720 |
| PAK_5339 | SN1046290829, PAK_5339 | PAK1, PAK2 | GDSC2 | 1730 |
| TAF1_5496 | SN1050393042, TAF1_5496 | TAF1 | GDSC2 | 1732 |
| ULK1_4989 | SN1049257073, ULK1_4989 | ULK1 | GDSC2 | 1733 |
| VSP34_8731 | SN1049998399, VSP34_8731 | VSP34 | GDSC2 | 1734 |
| IGF1R_3801 | SN1051640224, IGF1R_3801 | IGFR1 | GDSC2 | 1738 |
| JAK_8517 | SN1066590414, JAK_8517 | JAK1, JAK2 | GDSC2 | 1739 |
| GSK2256098C | FAK1 | GDSC2 | 1776 | |
| GSK2276186C | JAK1, JAK2, JAK3 | GDSC2 | 1777 | |
| GSK2110183B | AKT1, AKT2, AKT3 | GDSC2 | 1778 | |
| GSK626616AC | DYRK1A | GDSC2 | 1779 | |
| GSK3337463A | NIK | GDSC2 | 1780 | |
| GSK2830371A | PPM1D | GDSC2 | 1782 | |
| LMB_AB1 | ADRA1A, ADRB1 | GDSC2 | 1783 | |
| LMB_AB2 | GADD34 | GDSC2 | 1784 | |
| LMB_AB3 | PPP1R15B | GDSC2 | 1785 | |
| AZD4547 | 1035270-39-3 | FGFR1, FGFR2, FGFR3 | GDSC2 | 1786 |
| Ibrutinib | PCI-32765, CRA-032765, PCI-32765-00 | BTK | GDSC2 | 1799 |
| Zoledronate | Zoledronic acid, Zometa, Reclast | GDSC2 | 1802 | |
| Acetalax | Oxyphenisatin acetate | GDSC2 | 1804 | |
| Carmustine | GDSC2 | 1807 | ||
| Topotecan | TOP1 | GDSC2 | 1808 | |
| Teniposide | Vumon | GDSC2 | 1809 | |
| Mitoxantrone | TOP2 | GDSC2 | 1810 | |
| Dactinomycin | Actinomycin D, Cosmegen, Lyovac, Meractinomycin, Ac-De, ActD | RNA polymerase | GDSC2 | 1911 |
| Bleomycin | dsDNA break induction | GDSC2 | 1812 | |
| Fludarabine | Fludara | Antimetabolite | GDSC2 | 1813 |
| Nelarabine | Atriance, Arranon | GDSC2 | 1814 | |
| Dacarbazine | DTIC | CP11A | GDSC2 | 1815 |
| Romidepsin | Istodax, FK228, Depsipeptide | HDAC1, HDAC2, HDAC3, HDAC8 | GDSC2 | 1817 |
| Vincristine | GDSC2 | 1818 | ||
| 123829 | GDSC2 | 1820 | ||
| 765771 | GDSC2 | 1821 | ||
| 123138 | GDSC2 | 1824 | ||
| Podophyllotoxin bromide | GDSC2 | 1825 | ||
| 50869 | GDSC2 | 1826 | ||
| Dihydrorotenone | GDSC2 | 1827 | ||
| 720427 | GDSC2 | 1828 | ||
| 667880 | GDSC2 | 1829 | ||
| Gallibiscoquinazole | GDSC2 | 1830 | ||
| L-Oxonoreleagnine | GDSC2 | 1831 | ||
| 729189 | GDSC2 | 1832 | ||
| 741909 | GDSC2 | 1833 | ||
| 743380 | GDSC2 | 1834 | ||
| Elephantin | GDSC2 | 1835 | ||
| 150412 | GDSC2 | 1836 | ||
| Sinularin | GDSC2 | 1838 | ||
| 615590 | GDSC2 | 1839 | ||
| 630600 | GDSC2 | 1840 | ||
| LMP744 | MJ-III-65 | TOP1 | GDSC2 | 1843 |
| 776928 | GDSC2 | 1844 | ||
| Schweinfurthin A | GDSC2 | 1845 | ||
| BEN | GDSC2 | 1847 | ||
| Sabutoclax | BI-97C1 | BCL2, BCL-XL, BFL1, MCL1 | GDSC2 | 1849 |
| LY2109761 | 5XE | TGFB1 | GDSC2 | 1852 |
| OF-1 | BRPF1B, BRPF2 | GDSC2 | 1853 | |
| MN-64 | TNKS1, TNKS2 | GDSC2 | 1854 | |
| KRAS (G12C) Inhibitor-12 | GTPL8020 | KRAS (G12C) | GDSC2 | 1855 |
| MG-132 | LLL cpd, MG 132, MG132 | Proteasome, CAPN1 | GDSC2 | 1862 |
| BDP-00009066 | MRCKB_HUMAN | GDSC2 | 1866 | |
| Buparlisib | BKM120, NVP-BKM120 | PI3Kalpha, PI3Kdelta, PI3Kbeta, PI3Kgamma | GDSC2 | 1873 |
| Ulixertinib | BVD-523, VRT752271 | ERK1, ERK2 | GDSC2 | 2047 |
| Venetoclax | ABT-199, Veneclexta, GDC-0199 | BCL2 | GDSC2 | 1909 |
| ABT737 | BCL2, BCL-XL, BCL-W, BCL-B, BFL1 | GDSC2 | 1910 | |
| Afuresertib | GSK2110183, GSK2110183C | AKT1, AKT2, AKT3 | GDSC2 | 1912 |
| AGI-5198 | IDH-C35 | IDH1 (R132H) | GDSC2 | 1913 |
| AZD3759 | EGFR | GDSC2 | 1915 | |
| AZD5363 | AKT1, AKT2, AKT3, ROCK2 | GDSC2 | 1916 | |
| AZD6738 | AZD 6738, AZD-6738 | ATR | GDSC2 | 1917 |
| AZD8186 | AZD 8186, AZD-8186 | PI3Kalpha, PI3Kbeta | GDSC2 | 1918 |
| Osimertinib | AZD9291, AZD 9291, AZD-9291, Tagrisso, Mereletinib | EGFR | GDSC2 | 1919 |
| Cediranib | AZD2171, AZD 2171, AZD-2171, Recentin | VEGFR, FLT1, FLT2, FLT3, FLT4, KIT, PDGFRB | GDSC2 | 1922 |
| Ipatasertib | GDC0068, GDC 0068, GDC-0068 | AKT1, AKT, AKT3 | GDSC2 | 1924 |
| GDC0810 | GDC-0810, GDC 0810 | ESR1, ESR2 | GDSC2 | 1925 |
| GNE-317 | GNE317, GNE 317 | PI3Kalpha | GDSC2 | 1926 |
| GSK2578215A | GSK 2578215A, GSK-2578215A | LRRK2 | GDSC2 | 1927 |
| I-BRD9 | GSK602, GSK 602, GSK-602 | BRD9 | GDSC2 | 1928 |
| Telomerase Inhibitor IX | MST-312, MST 312, MST312 | Telomerase | GDSC2 | 1930 |
| MIRA-1 | MIRA 1, MIRA1, NSC19630, NSC-19630, NSC 19630 | TP53 | GDSC2 | 1931 |
| NVP-ADW742 | NVP ADW742, NVPADW742 | IGF1R | GDSC2 | 1932 |
| P22077 | P 22077, P-22077 | USP7, USP47 | GDSC2 | 1933 |
| Savolitinib | AZD6094, Volitinib, AZD-6094, AZD 6094 | MET | GDSC2 | 1936 |
| UMI-77 | UMI 77, UMI-77 | MCL1 | GDSC2 | 1939 |
| WIKI4 | WIKI-4, WIKI 4 | TNKS1, TNKS2 | GDSC2 | 1940 |
| Sepantronium bromide | YM155, YM-155, YM 155 | BIRC5 | GDSC2 | 1941 |
| MIM1 | MIM 1, MIM-1 | MCL1 | GDSC2 | 1996 |
| WEHI-539 | WEHI539, WEHI-539 | BCL-XL | GDSC2 | 1997 |
| BPD-00008900 | GDSC2 | 1998 | ||
| N25720-51-A1 | GDSC2 | 1999 | ||
| N27922-53-1 | GDSC2 | 2000 | ||
| N30652-18-1 | GDSC2 | 2002 | ||
| N29087-69-1 | GDSC2 | 2003 | ||
| HKMTI-1-005 | GDSC2 | 2010 | ||
| ICL-SIRT078 | SIR2 | GDSC2 | 2011 | |
| UNC0638 | G9A, GLP | GDSC2 | 2038 | |
| AGK2 | BAZ2A, BAZ2B | GDSC2 | 2039 | |
| Foretinib | GSK1363089, XL-880, EXEL-2880, GSK089 | MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR | GDSC2 | 2040 |
| BIBR-1532 | TERT | GDSC2 | 2043 | |
| Pyridostatin | G-quadruplex stabiliser | GDSC2 | 2044 | |
| AMG-319 | AMG319 | PI3K (beta sparing) | GDSC2 | 2045 |
| MK-8776 | SCH900776 | CHEK1, CHEK2, CDK2 | GDSC2 | 2046 |
| Vinorelbine | vinorelbine tartrate, Navelbine, Exelbine | Microtubule destabiliser | GDSC2 | 2048 |
| Mycophenolic acid | GDSC2 | 2055 | ||
| Remodelin | GDSC2 | 2057 | ||
| VX-11e | VX11e, VX11e | ERK2 | GDSC2 | 2096 |
| LJI308 | RSK2, RSK1, RSK3 | GDSC2 | 2107 | |
| AZ6102 | TNKS1, TNKS2 | GDSC2 | 2109 | |
| GSK591 | EPZ015866, GSK3203591 | PMRT5 | GDSC2 | 2110 |
| VE821 | VE 821, VE-821 | ATR | GDSC2 | 2111 |
| VTP-A | GDSC2 | 2112 | ||
| VTP-B | GDSC2 | 2113 | ||
| PBD-288 | GDSC2 | 2145 | ||
| POMHEX | GDSC2 | 2148 | ||
| CT7033-2 | KDM4A, KDM4C, KDM4E, KDM3A, KDM6B | GDSC2 | 2149 | |
| GSK-LSD1-2HCl | LSD1 | GDSC2 | 2154 | |
| 5-azacytidine | DNA methyltransferases | GDSC2 | 2156 | |
| A-366 | EHMT1, EHMT2 | GDSC2 | 2157 | |
| CPI-637 | EP300 | GDSC2 | 2158 | |
| UNC0379 | SETD8 | GDSC2 | 2159 | |
| AZD6482 | AZD 6482, AZD-6482, AK-55409 | PI3Kbeta | GDSC2 | 2169 |
| AT13148 | AKT1 | GDSC2 | 2170 | |
| BMS-754807 | BMS-754807 | IGF1R, IR | GDSC2 | 2171 |
| JQ1 | JQ-1, (+)-JQ-1 | BRD2, BRD3, BRD4, BRDT | GDSC2 | 2172 |
| PFI-1 | BRD4 | GDSC2 | 2173 | |
| IOX2 | IOX-2, IOX 2, AK176060 | EGLN1 | GDSC2 | 2174 |
| CHIR-99021 | CT 99021, CHIR99021, CHIR 99021 | GSK3A, GSK3B | GDSC2 | 2175 |
| SGC0946 | DOT1L | GDSC2 | 2177 | |
| GSK2830371 | None | WIP1 | GDSC2 | 2359 |
| THR-101 | WIMM synthesis | Mutant RAS | GDSC2 | 2360 |
| THR-102 | WIMM synthesis | Mutant RAS | GDSC2 | 2361 |
| THR-103 | WIMM synthesis | Mutant RAS | GDSC2 | 2362 |
| ascorbate (vitamin C) | back-up solution from YWKim | anti-oxidant proteins | GDSC2 | 2438 |
| glutathione | G6013, sigma | anti-oxidant proteins | GDSC2 | 2439 |
| alpha-lipoic acid | aLA | Metabolism | GDSC2 | 2498 |
| N-acetyl cysteine | NAC | Metabolism | GDSC2 | 2499 |
| Geldanamycin | Hsp90 inhibitor | |||
| Sirolimus | mTOR inhibitor |